You just read:

Biohaven Completes Enrollment In Pivotal Phase 2/3 Alzheimer's Disease Clinical Trial Of Troriluzole

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Nov 05, 2019, 07:30 ET